Cargando…

Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis

Recombinant beta interferons-1 (IFNβ-1) are used as first line therapies in patients with relapsing multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the CNS. IFNβ-1a/b has moderate effects on the prevention of relapses and slowing of disease progression. Fibroblast gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajendran, Ranjithkumar, Rajendran, Vinothkumar, Gupta, Liza, Shirvanchi, Kian, Schunin, Darja, Karnati, Srikanth, Giraldo-Velásquez, Mario, Berghoff, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603153/ https://www.ncbi.nlm.nih.gov/pubmed/36293040 http://dx.doi.org/10.3390/ijms232012183

Ejemplares similares

Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG(35-55)-Induced EAE
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling
por: Kamali, Salar, et al.
Publicado: (2021)

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

Interferon beta-1a–induced morphea
por: Bezalel, Spencer A., et al.
Publicado: (2014)

Interferon beta-1b for COVID-19
por: Shalhoub, Sarah
Publicado: (2020)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Immunomodulatory activity of interferon-beta
por: Kasper, Lloyd H, et al.
Publicado: (2014)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
por: van Beers, Miranda M. C., et al.
Publicado: (2011)

Pregnancy outcomes in patients exposed to interferon beta-1b
por: Romero, Rebecca S, et al.
Publicado: (2015)

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
por: Weller, Ivonne, et al.
Publicado: (2015)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis
por: Shahi, Shailesh K., et al.
Publicado: (2020)

Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue
por: Dubey, S., et al.
Publicado: (2020)

Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients
por: Seyfi, Shahram, et al.
Publicado: (2021)

Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis
por: Marziniak, Martin, et al.
Publicado: (2014)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
por: Reuss, Reinhard
Publicado: (2013)

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

HSPD1 Interacts with IRF3 to Facilitate Interferon-Beta Induction
por: Lin, Lan, et al.
Publicado: (2014)

Effects of Systemic and Local Interferon Beta-1a on Epidural Fibrosis
por: Taşkapılıoğlu, Mevlüt Özgür, et al.
Publicado: (2016)

Interferon-beta-1a/natalizumab: Lack of efficacy: case report
Publicado: (2021)

Multiple human beta interferon genes
Publicado: (1982)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection
por: Schwerdtfeger, Mara, et al.
Publicado: (2022)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Paolicelli, Damiano, et al.
Publicado: (2009)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Jankovic, Slobodan M
Publicado: (2010)

Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis
por: Mazdeh, Mehrdokht, et al.
Publicado: (2012)

Unusual Side Effects of Interferon Beta-1a in Patient with Multiple Sclerosis
por: Tavakoli, Maryam, et al.
Publicado: (2012)

Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy
por: Zettl, Uwe Klaus, et al.
Publicado: (2016)

Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection
por: Akhbari, Pouria, et al.
Publicado: (2020)

Interferon beta-1a for COVID-19: critical importance of the administration route
por: Jalkanen, Juho, et al.
Publicado: (2020)

Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid
por: Sultana, Tahmina, et al.
Publicado: (2019)

Comparative Toxicity of Interferon Beta-1a Impurities of Heavy Metal Ions
por: Berillo, Dmitriy
Publicado: (2022)

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial
por: Alavi Darazam, Ilad, et al.
Publicado: (2021)

Inhibition of suppressor T lymphocytes by murine interferon beta
Publicado: (1987)

Thrombotic microangiopathy associated with use of interferon-beta
por: Olea, Teresa, et al.
Publicado: (2012)

Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_b0ro9iaqcr7l93r1g2bqfg505j